These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 27894233)
41. Serotonin syndrome in a child associated with erythromycin and sertraline. Lee DO; Lee CD Pharmacotherapy; 1999 Jul; 19(7):894-6. PubMed ID: 10417041 [TBL] [Abstract][Full Text] [Related]
42. Forme fruste of neuroleptic malignant syndrome associated with the use of sertraline. Miranda M; Soto F; Fischman P Parkinsonism Relat Disord; 2011 Mar; 17(3):217-8. PubMed ID: 21147016 [No Abstract] [Full Text] [Related]
43. Serotonin syndrome from sertraline monotherapy. Duignan KM; Quinn AM; Matson AM Am J Emerg Med; 2020 Aug; 38(8):1695.e5-1695.e6. PubMed ID: 31837902 [TBL] [Abstract][Full Text] [Related]
48. Sertraline-induced hyponatremia in the elderly. Agrawal NK; Rastogi A; Goyal R; Singh SK CJEM; 2007 Nov; 9(6):415. PubMed ID: 18072985 [No Abstract] [Full Text] [Related]
49. An evidence-based review of the clinical use of sertraline in mood and anxiety disorders. Sheehan DV; Kamijima K Int Clin Psychopharmacol; 2009 Mar; 24(2):43-60. PubMed ID: 21456103 [TBL] [Abstract][Full Text] [Related]
50. Platelet function defects and sertraline-induced bleeding: a case report. Strumia M; Guerrero F; Maurel-Ribes A; Garcia C; Payrastre B; Bagheri H Fundam Clin Pharmacol; 2020 Oct; 34(5):632-636. PubMed ID: 32125025 [TBL] [Abstract][Full Text] [Related]
51. Sertraline treatment of interferon-alfa-induced depressive disorder. Schramm TM; Lawford BR; Macdonald GA; Cooksley WG Med J Aust; 2000 Oct; 173(7):359-61. PubMed ID: 11062791 [TBL] [Abstract][Full Text] [Related]
53. Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome. Duval F; Flabeau O; Razafimahefa J; Spampinato U; Tison F Mov Disord; 2013 Sep; 28(10):1464. PubMed ID: 23495033 [No Abstract] [Full Text] [Related]
54. Sertraline versus other antidepressive agents for depression. Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C Cochrane Database Syst Rev; 2010 Jan; (1):CD006117. PubMed ID: 20091586 [TBL] [Abstract][Full Text] [Related]
55. Sertraline versus other antidepressive agents for depression. Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C Cochrane Database Syst Rev; 2009 Apr; (2):CD006117. PubMed ID: 19370626 [TBL] [Abstract][Full Text] [Related]
56. Sertraline versus other antidepressive agents for depression. Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C Cochrane Database Syst Rev; 2010 Apr; (4):CD006117. PubMed ID: 20393946 [TBL] [Abstract][Full Text] [Related]
57. Sertraline-induced rhabdomyolysis in an elderly patient with dementia and comorbidities. Gareri P; Segura-García C; De Fazio P; De Fazio S; De Sarro G Ann Pharmacother; 2009 Jul; 43(7):1354-9. PubMed ID: 19567656 [TBL] [Abstract][Full Text] [Related]
58. Severe sleep-related movement disorder induced by sertraline. Bušková J; Vorlová T; Piško J; Sonka K Sleep Med; 2012 Jun; 13(6):769-70. PubMed ID: 22440086 [No Abstract] [Full Text] [Related]
59. Sertraline hepatotoxicity: a case report and review of the literature on selective serotonin reuptake inhibitor hepatotoxicity. Persky S; Reinus JF Dig Dis Sci; 2003 May; 48(5):939-44. PubMed ID: 12772794 [TBL] [Abstract][Full Text] [Related]
60. Antidepressants in depressed patients with irritable bowel syndrome. Efremova I; Asnis G Am J Psychiatry; 1998 Nov; 155(11):1627-8. PubMed ID: 9812134 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]